BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, April 26, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Regulatory actions for March 10, 2026

March 10, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, BMS, Chiesi, Claritas, Daiichi, Immunitybio, Incyte, Johnson & Johnson, Junshi, MBX, Nanosonics, PMV, Precision, Protalix, Sangamo, Savara.
Read More

Other news to note for March 10, 2026

March 10, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Actuate, Baymedica, DT-Axis, Eledon, Etcembly, Fujitsu, Galecto, Inmed, Kuva Labs, Kyron.bio, Lisata, Newcelx, Servier, Zelluna.
Read More

In the clinic for March 10, 2026

March 10, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Atamyo, Benitec, Biofrontera, BMS, Bonesupport, Castle, Crestone, Dianthus, Dyne, Ipsen, ITF, Keros, Novabridge, Novelmed, Numares, Pfizer, Pulse, Regeneron, Relmada, Roche, Santhera, Spyglass, TG, Tris, Visara, Xenon.
Read More

Financings for March 10, 2026

March 10, 2026
Biopharma and med-tech companies raising money in public or private financings, including: AN2, Defence, Invea, Korro, Lyell, Relmada, SS Innovations, Telo Genomics.
Read More

Appointments and advancements for March 10, 2026

March 10, 2026
New hires and promotions in the biopharma and med-tech industries, including: Biomx, Ionis, LB, Lobe Sciences, Lyell, Spruce, Tevogen.
Read More

Regulatory actions for March 10, 2026

March 10, 2026
Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Accord, Asieris, Claritas, Drug Farm, Foresee, Glenmark, Nxera, Hua Medicine, Innocare, Innovent, Meiji, Pepgen, Pharmaessentia, Protagonist, Sanofi, Sciwind, Sumitomo, Takeda.
Read More

Other news to note for March 10, 2026

March 10, 2026
Biopharma and med-tech happenings in Asia-Pacific, including deals and partnerships, and other news in brief: Bcworld, Beam, Bio Palette, Celltype, Congruence, Daiichi Sankyo, Gaia, Grünenthal, GSK, Immunis, Ono, Rapport, Rapt, Senhwa, Shanghai Jeyou, Sinopia, Takeda, Tenacia, Toray.
Read More

In the clinic for March 10, 2026

March 10, 2026
Clinical updates for biopharma and med tech in Asia-Pacific, including data readouts and publications: Akeso, Kyowa Kirin.
Read More

Appointments and advancements for March 10, 2026

March 10, 2026
New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: Alterity, Argo, Hutchmed.
Read More

Regulatory actions for March 9, 2026

March 9, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Accord, Claritas, Foresee, Johnson & Johnson, Lifevac, Royal Philips, Sciwind, Soterix, Sumitomo.
Read More
Previous 1 2 … 18 19 20 21 22 23 24 25 26 … 1786 1787 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 24, 2026.
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • Boy cupping ear with soundwave graphic

    A free gene therapy? Regeneron’s Otarmeni approved for hearing loss

    BioWorld
    Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • In the clinic for April 21, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing